Study Says ivWatch Detects IV Infiltrations and Extravasations Before Clinicians
The study, published in The Journal of Vascular Access, examined the performance of the device at Wilhelmina Children’s Hospital.
The ivWatch is a continuous monitoring system developed by ivWatch LLC. Along with the monitoring, the device is also equipped with early detection capabilities and is used to detect IV infiltrations and extravasations.
A study published in The Journal of Vascular Access suggests that the device can detect these events earlier than clinicians are able, according to a new press release. The device was deployed at the Wilhemina Children’s Hospital in the Netherlands, where it was used in a 24-bed neonatal care unit.
The results of the study consistently showed the ivWatch detecting events before clinicians.
The device uses a predictive algorithm and near-infrared light to detect alterations in the tissue around an IV site. If a change is detected, the clinicians are immediately notified.
New machine-learning approach could speed precision drug development
The approach, detailed this week in the journal Nature, uses a platform called Molecular Surface Interaction Fingerprinting (MaSIF) to design custom proteins that bind to drug-bound target proteins.
AI-enabled CGM app shows promise for glycemic control, weight management
The broader implications of this study suggest that digital health platforms like January V2 have the potential to play a crucial role in the future of chronic disease management,” the authors write.
